Neurological Complications of Systematic Cancer and Antineoplastic Therapy, Second Edition provides an expanded, updated and in-depth review of common manifestations related to neurology that occur in patients with systemic cancer. These include brain metastases, spinal cord compression, cerebrovascular events, and leptomeningeal disease. The book also discusses neurological complications related to treatments such as radiation and chemotherapy and is an essential reference for the practicing neurologist and oncologist.
Sections in this new release cover the pathophysiology and molecular biology of cancer and the metastatic phenotype, Metastatic spread to cranial and peripheral nerves and brachial and lumbosacral plexuses, Metabolic and nutritional disorders, CNS infections, Neurological complications of immunotherapy and bone marrow transplants, Neurological complications of new molecular agents and immuno-modulatory drugs, and more.
Auflage
Sprache
Verlagsort
Verlagsgruppe
Elsevier Science Publishing Co Inc
Zielgruppe
Maße
Höhe: 276 mm
Breite: 216 mm
Gewicht
ISBN-13
978-0-12-821976-8 (9780128219768)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
Herbert B. Newton, M.D., FAAN, is currently the Medical Director for the Neuro-Oncology Program and Brain Tumor Institute at the University Hospitals Cleveland Medical Center and Seidman Cancer Center, in Cleveland, Ohio, where he is also a Professor of Neurology and Solid Tumor Oncology, and holds the William Burton Risman Neurological Institute Chair in Memory and Cognition. Prior to that he was the Director of the Neuro-Oncology Center and Medical Neuro-Oncology Program at the Advent Health Cancer Institute and Advent Health Orlando Campus in Orlando, Florida. He is also retired as a Professor of Neurology and Neurosurgery, Dardinger Neuro-Oncology Center, Esther Dardinger Endowed Chair in Neuro-Oncology and Division of Neuro-Oncology at the Ohio State University Medical Center and James Cancer Hospital, in Columbus, Ohio. He is a Diplomate of the American Board of Psychiatry and Neurology, a Fellow of the American Academy of Neurology and Royal Society of Medicine, and a member of numerous national and international societies.
Dr. Malkin is currently the Director of the Neuro-Oncology Program at Massey Cancer Center, and Director of the Neuro-Oncology Division, in the Department of Neurology at Virginia Commonwealth University School of Medicine. He holds the William G. Reynolds, Jr. Chair in Neuro-Oncology and is Professor of Neurology. Before his appointment at VCU, he was the Director of Neuro-Oncology and Professor of Neurology at Froedtert and the Medical College of Wisconsin. Prior to his move to Milwaukee, he was an Associate Clinical Member at Memorial Sloan-Kettering Cancer Center and Associate Clinical Professor of Neurology at Weill Cornell Medical College. He also trained in Neuro-Oncology with Drs. Jerome Posner and William Shapiro at Memorial Sloan-Kettering Cancer Center, and since then has been in academic Neuro-Oncology for over 33 years. He has published more than 100 peer-reviewed articles and book chapters and is Co-Editor of several textbooks in the field of Neuro-Oncology.
Herausgeber*in
Neuro-Oncology Program and Brain Tumor Institute at the University Hospitals Cleveland Medical Center and Seidman Cancer Center
SECTION I. Metastatic Neurological Complications
1. Common symptoms at presentation of nervous system metastases
2. Neuroimaging of systemic metastatic disease
3. Nonimaging evaluation of patients with nervous system metastases
4. Biology and pathophysiology of central nervous system metastases
5. Intracranial metastases
6. Neurosurgical approaches to the treatment of intracranial metastases
7. Epidural metastasis and spinal cord compression
8. Leptomeningeal metastasis
9. Cranial nerve involvement by metastatic cancer
10. Cancer-related plexopathies
SECTION II. Nonmetastatic Neurological Complications
11. Cerebrovascular complications of malignancy
12. Metabolic and nutritional nervous system dysfunction in cancer patients
13. Central nervous system infections in cancer patients
14. Diagnosis and treatment of paraneoplastic neurological disorders
SECTION III. Neurological Complications of Specific Neoplasms
15. Neurological complications of lung cancer
16. Neurological complications of breast cancer
17. Neurological complications of melanoma
18. Neurological complications of lymphoma
19. Neurological complications of the leukemias
20. Neurological complications of systemic cancer of the head and neck 21. Neurological complications of gynecological cancers
22. Neurological complications of GI cancers
23. Neurologic complications associated with genitourinary cancer
24. Sarcoma and the nervous system
25. Neurological complications of multiple myeloma
26. Neurologic complications in the treatment of childhood malignancies
SECTION IV. Neurological Complications of Antineoplastic Therapy
27. Neurological complications of radiation therapy
28. Neurological complications of systemic cancer and antineoplastic therapy
29. Neurological complications of hematopoietic stem cell transplantation
30. Chemotherapy-induced peripheral neuropathy
31. Neurological complications of immunotherapy and monoclonal antibody therapy
32. Neurological complications of immune modulatory therapy
33. Neurological complications of steroids and of supportive care
SECTION V. Psychiatric, Pain, Psychosocial, and Supportive Care Issues
34. Psychiatric aspects of care in the cancer patient
35. Chronic cancer pain syndromes and their treatment
36. Psychosocial issues in cancer patients with neurological complications
37. Supportive care
